Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...

According to the Dickerson’s Pharmacy mission, they are “Saving patients time and money and cherishing friendships in Bladen ...

Independent drugstores are closing at an alarming rate, squeezed by the huge companies that reimburse pharmacies for costly ...

A pharmacy terminated from OptumRx Inc.'s benefits network must arbitrate its state and federal insurance and tort law claims against the pharmacy benefits manager, even though they never formally ...

Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...

They deserve a raise, KEEP THEM. The pharmacy located at 5969 Lankershim Blvd. North Hollywood, CA 91601 Manager ** assisted me and Medi-Cal as well as My Dr office with above and beyond ...